Literature DB >> 11411764

Development and application of a biological peptide pump for the study of the in vivo actions of angiotensin peptides.

D Methot1, J P vanKats, N Lochard, F Tremblay, D W Silversides, T L Reudelhuber.   

Abstract

In the past few years, a great deal of interest has been focused on the possibility that angiotensin peptides could have direct effects on target tissues independent of their hemodynamic effects. In addition, there has been much speculation on the potential biological roles of angiotensin peptides other than angiotensin II. Unfortunately, a direct test of these possibilities in whole animals has been difficult due to limitations in existing biological systems. In this review, we describe the characteristics of an engineered protein capable of directing the production of a wide variety of peptides to specific tissues and cell types in transgenic animals and discuss its potential applications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411764     DOI: 10.1016/s0895-7061(01)02068-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

Review 1.  Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging.

Authors:  Debra I Diz
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

2.  A genetically clamped renin transgene for the induction of hypertension.

Authors:  Kathleen M I Caron; Leighton R James; Hyung-Suk Kim; Scott G Morham; Maria Luisa S Sequeira Lopez; R Ariel Gomez; Timothy L Reudelhuber; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.

Authors:  YanFei Qi; Vinayak Shenoy; Fong Wong; Hongwei Li; Aqeela Afzal; J Mocco; Colin Sumners; Mohan K Raizada; Michael J Katovich
Journal:  Exp Physiol       Date:  2011-06-17       Impact factor: 2.969

4.  Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene.

Authors:  Kathleen M I Caron; Leighton R James; Hyung-Suk Kim; Josh Knowles; Rick Uhlir; Lan Mao; John R Hagaman; Wayne Cascio; Howard Rockman; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

5.  Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.

Authors:  Caroline Fattah; Katrin Nather; Charlotte S McCarroll; Maria P Hortigon-Vinagre; Victor Zamora; Monica Flores-Munoz; Lisa McArthur; Lorena Zentilin; Mauro Giacca; Rhian M Touyz; Godfrey L Smith; Christopher M Loughrey; Stuart A Nicklin
Journal:  J Am Coll Cardiol       Date:  2016-12-20       Impact factor: 24.094

6.  AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo.

Authors:  Xinglu Chen; Sansan Chen; Nana Pei; Yingying Mao; Shengyao Wang; Renhe Yan; Na Bai; Andrew Li; Yanling Zhang; Hongyan Du; Baihong Chen; Colin Sumners; Jinlong Li; Hongwei Li
Journal:  Oncotarget       Date:  2017-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.